Chronic Fatigue Syndrome Will Be First Of PDUFA V’s Disease Area Meetings
From BioPharma Today
March 11, 2013 - 5:10pm
FDA is bringing an ongoing program to spur drug development for CFS and myalgic encephalomyelitis under the umbrella of the user fee program’s Patient-Focused Drug Development initiative, which calls for 20 patient-centric meetings over five years.
March 11, 2013 - 5:10pm
Share This Article:
Pharma Buzz
- May26 2:47amStrategies for improving communication between scientists and the public
- May26 1:00amAre America’s Nutrition Professionals in the Pocket of Big Food?
- May25 1:45pmMy Mistake! The Rumored Price Is Three AND A HALF TIMES B + L's 2012 Sales Revenue; Over 20 Times 2012 GAAP Earnings!
- May25 11:40amIs FDA Covering Its Fanny on Avandia?
- May25 1:00amDoes a Pepper a Day Keep Parkinson’s Away?
- May25 1:00amThe Great Plow-Up
- May24 10:17pmACI "4th Advanced Forum on Biosimilars," New York City, June 5-7
- May24 7:44pmRunning a Pharm-Free Office: One Group's Story
- May24 5:55pmJ&J Taking The Long View With Its Therapeutic Franchises
- May24 5:35pmSecond Phase Of Takeda’s Globalization Plan Calls For Partial Integration Of Millennium
- May24 4:35pmRecent Violence Targeted At Doctors In China Could Spell Trouble For Clinical Trials
- May24 4:05pmMerck Halts Preladenant Development In Parkinson’s Following Phase III Failures
- May24 3:15pmThird Rock’s Mark Levin Warns of System-Wide Failure To Support Young Biomedical Companies
- May24 2:38pmRumor Mill Grist: Quiet Pre-Holiday Friday "Fast Fred" Chronicles Edition
- May24 2:35pmWar Of Words: Pfizer Battles With Top Indian Pharma Lobby On Key Policy Issues
- May24 2:05pmLet The Blame Game Begin: Former Ranbaxy Promoter Spars With Daiichi Sankyo
- May24 1:15pmRepros Needs Another Mid-Stage Trial For Proellex In Uterine Fibroids
- May24 12:30pmAmid a legal dispute, journal downgrades a retraction to an expression of concern
- May24 11:42amAbbVie takes some heat for raising price of Niaspan after studies panned it
- May24 11:40amDeals Of The Week Ponders When $2.1 Billion Is A Steal
- May24 11:02amEuropean Union Approves Restrictions on Three Pesticides to Protect Dwindling Bee Populations
- May24 10:45amNovartis apologizes over Diovan study as probe shows employee involvement in trials
- May24 10:26amWeekly Roundup 5-24-13
- May24 9:50amFormer Carl Icahn proxy brawler Alex Denner joins fight against Vivus board
- May24 9:43amCall for fact-checking over transcription: Questions journalists should ask about a psych drug trial suicide
- May24 9:36amNation's Most Populous State Unwraps Its Health Care Exchange -- And At Least 13 Private Insurers Join The Effort
- May24 9:33amCardiology journals retract five Matsubara studies
- May24 9:11amA New Way to Determine Chirality
- May24 8:59amCombating 'hidden hunger' with Vitamin Angels
- May24 8:59amAERs – A unique opportunity to build confidence in supplements: SafetyCall
- May24 8:59amTime for mandatory folic acid fortification to go truly global?
- May24 8:59amVitamin Angels: We could reach 100 million kids tomorrow if we had the funding
- May24 8:53amJ&J Embraces "Special K" for Depression - Why Not Medical Marijuana?
- May24 8:45amCLS Bank International v. Alice Corporation: Poison Apple
- May24 8:39amJ&J plans 25 lines extensions in next four years
- May24 8:34amMore Columns Coming; The Alliance for a Stronger FDA
- May24 8:30amUlrich Lichtenthaler now up to 12 retractions
- May24 8:00amNew Medical Device Preemption Win
- May24 7:55am Contributor
- May24 7:31amBRIC markets turning out to be tougher to mine than expected
- May24 4:40amIndia Adopts Guidelines To Comply With EU Drug-Quality Import Rules
- May24 4:36amDrug price control order (DPCO) 2013 : What's in store?
- May24 4:35amJ&J Pakistan Seeks Buyer As MNCs Reconsider Local Market
- May24 4:25amSaudi Arabia Cites Foreign Patents Of Coronavirus For Slowing Diagnosis
- May24 2:00amEmerging Company In An Emerging Market: Generon Sees Quality And Price As Litmus Test
- May24 1:00amGuangdong May Group Drugs Into Five Types For Separate Price Review
- May24 1:00amIntravenous Nutrition Within 24 Hours Doesn’t Improve Survival
- May24 12:55amNatural & Clean Label Trends 2013: How clean is your label? And can GMOs ever belong in 'natural' products?
- May24 12:00amMarketing to the Big Data Inside Us
- May23 11:25pmJ&J Sees New MOAs For Refractory Populations As Anti-Depressant For Neuro Sales
